Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead Announces Results from Phase 2 Study Showing Reduction in Atrial Fibrillation Burden with the Investigational Combination of Ranolazine and Low-Dose Dronedarone
Yahoo/BusinessWire
Sun, 05/11/14 - 10:30 am
Gilead Sciences
dronedarone
ranolazine
atrial fibrilation
Gilead announces Phase 1 data for GS-6615
The Fly on the Wall
Sat, 05/10/14 - 10:32 am
Gilead Sciences
GS-6615
long QT
J&J /Gilead HCV Combo Drug Filed
Yahoo/Zacks.com
Thu, 05/8/14 - 05:20 pm
JNJ
Gilead Sciences
hepatitis C
Olysio
Sovaldi
Cancer Doctors Join Insurers in U.S. Drug-Cost Revolt
Bloomberg
Wed, 05/7/14 - 08:17 am
physicians
drug costs
Gilead Sciences
Sovaldi
cancer
Gilead Sciences - Sovaldi's Pricing In A New Perspective
Seeking Alpha
Mon, 05/5/14 - 05:02 pm
Gilead Sciences
Sovaldi
hepatitis C
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Mon, 05/5/14 - 08:26 am
Merck
Bristol-Myers Squibb
Gilead Sciences
Roche
MK-3475
hepatitis C
Why Sovaldi shouldn't cost $84,000
Modern Healthcare
Sun, 05/4/14 - 11:59 am
Sovaldi
hepatitis C
hepatitis
Gilead Sciences
WellPoint says hepatitis C drugs Q1 cost was $50 mln
Yahoo/Reuters
Wed, 04/30/14 - 01:08 pm
hepatitis C
drug costs
Wellpoint
Sovaldi
Gilead Sciences
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Wed, 04/30/14 - 12:37 pm
Gilead Sciences
Teva Pharmaceuticals
Copaxone
Idelalisib
Bristol-Myers Squibb
nivolumab
Cyramza
Eli Lilly
Pfizer
palbociclib
Sovaldi
Drug Merger Boom Sends Hedging Costs to Eight-Year High
Bloomberg
Wed, 04/30/14 - 08:39 am
M&A
Gilead Sciences
Forest Labs
Pfizer
Allergan
Eli Lilly
Gilead's Sovaldi Is The Solution, Not The Problem
Seeking Alpha
Tue, 04/29/14 - 03:17 pm
Gilead Sciences
Sovaldi
At $1,000 A Pill, Hepatitis C Drug Sovaldi Rattles Medicaid Programs
Forbes
Mon, 04/28/14 - 09:20 am
hepatitis C
Gilead Sciences
Sovaldi
Medicaid
Say Hello to 3 Existing and Upcoming Next-Generation Blockbuster Drugs
Motley Fool
Sun, 04/27/14 - 09:51 am
Sovaldi
Gilead Sciences
Imbruvica
Pharmacyclics
JNJ
Eliquis
Bristol-Myers Squibb
Pfizer
Say Hello to the New Fastest Growing Drug in History!
Motley Fool
Wed, 04/23/14 - 12:36 pm
Gilead Sciences
Sovaldi
hepatitis C
drug launches
Today's Health Care Stocks to Watch: Illumina Inc., Intuitive Surgical Inc. and Gilead Sciences
Motley Fool
Wed, 04/23/14 - 10:41 am
Illumina
Intuitive Surgical
earnings
devices
Gilead Sciences
Gilead: X-Marks The Spot For Sovaldi Sales
Seeking Alpha
Wed, 04/23/14 - 10:18 am
Gilead Sciences
Sovaldi
hepatitis C
Incyte
Clovis Oncology
Puma Biotechnology
Gilead profit triples, hepatitis C drug revenue reaches $2.3 bln
Yahoo/Reuters
Tue, 04/22/14 - 04:54 pm
Gilead Sciences
earnings
What to Watch for in Biotech Earnings This Week
Motley Fool
Tue, 04/22/14 - 09:33 am
biotech
earnings
Gilead Sciences
Celgene
Amgen
BiogenIdec
Gilead Results Can Affect The Entire Market
Seeking Alpha
Mon, 04/21/14 - 11:45 am
Gilead Sciences
Sovaldi
earnings
Cost of Treatment May Influence Doctors
NY Times, NY
Fri, 04/18/14 - 09:30 am
physicians
Sovaldi
Gilead Sciences
Pages
« first
‹ previous
…
74
75
76
77
78
79
80
81
82
…
next ›
last »